Structural investigations on nanoemulsions, solid lipid nanoparticles and nanostructured lipid carriers by cryo-field emission scanning electron microscopy and Raman spectroscopy

International Journal of Pharmaceutics

Volumn 314, Issue 1, 2006, Pages 56-62

  Saupe, Anne ^a   Gordon, Keith C ^a   Rades, Thomas ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Cryo FESEM; Nanostructured lipid carriers; Raman spectroscopy; Solid lipid nanoparticles

Indexed keywords

DRUG CARRIER; SOLID LIPID NANOPARTICLE;

ANALYTIC METHOD; ARTICLE; CONTROLLED DRUG RELEASE; CRYO FIELD EMISSION SCANNING ELECTRON MICROSCOPY; CRYSTAL STRUCTURE; DIFFUSION; DISPERSION; INFRARED SPECTROSCOPY; LASER DIFFRACTION; PARTICLE SIZE; PHOTON CORRELATION SPECTROSCOPY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RAMAN SPECTROMETRY; STRUCTURE ANALYSIS; TEMPERATURE;

CHEMISTRY, PHARMACEUTICAL; CRYOELECTRON MICROSCOPY; DRUG CARRIERS; EMULSIONS; LIPIDS; MICROSCOPY, ELECTRON, SCANNING; NANOSTRUCTURES; SPECTRUM ANALYSIS; SPECTRUM ANALYSIS, RAMAN;

EID: 33646106067     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2006.01.022     Document Type: Article

References (25)

1. Andreev G., Schrader B., Schulz H., Fuchs R., Popov S., and Handjieva N. Fresen. J. Anal. Chem. 371 (2001) 1009-1017
2. Bunjes H., Westesen K., and Koch M.H.J. Int. J. Pharm. 129 (1996) 159-173
3. Dollish F.R., Fateley W., Bentley F., 1973. Charecteristic Roman Frequencies of Organic Compounds, Wiley-Interscience, New York.
4. Gohla S.H., and Dingler A. Die Pharmazie 56 (2001) 61-63
5. Jenning V., Gysler A., Schafer-Korting M., and Gohla S.H. Eur. J. Pharm. Biopharm. 49 (2000) 211-218
6. Jenning V., Mader K., and Gohla S.H. Int. J. Pharm. 205 (2000) 15-21
7. Jenning V., Thunemann A.F., and Gohla S.H. Int. J. Pharm. 199 (2000) 167-177
8. Jores, K., 2004. Lipid nanodispersions as drug carrier systems - a physicochemical characterization. Ph.D. Thesis. Martin-Luther-Universität Halle-Wittenberg.
9. Jores K., Mehnert W., Drechsler M., Bunjes H., Johann C., and Mader K. J. Control. Release 95 (2004) 217-227
10. Liedtke S., Wissing S., Muller R.H., and Mader K. Int. J. Pharm. 196 (2000) 183-185
11. Lippacher A., Muller R.H., and Mader K. Eur. J. Pharm. Biopharm. 53 (2002) 155-160
12. Lippacher A., Muller R.H., and Mader K. Eur. J. Pharm. Biopharm. 58 (2004) 561-567
13. Mehnert W., and Mader K. Adv. Drug Deliv. Rev. 47 (2001) 165-196
14. Muller R.H., Mader K., and Gohla S. Eur. J. Pharm. Biopharm. 50 (2000) 161-177
15. Muller R.H., Radtke M., and Wissing S.A. Int. J. Pharm. 242 (2002) 121-128
16. Pouton C.W. Eur. J. Pharm. Sci. 11 (2000) S93-S98
17. Pratiwi D., Fawcett J.P., Gordon K.C., and Rades T. Eur. J. Pharm. Biopharm. 54 (2002) 337-341
18. Saupe A., Wissing S.A., Lenk A., Schmidt C., and Muller R.H. Biomed. Mater. Eng. 15 (2005) 393-402
19. Tandon P., Forster G., Neubert R., and Wartewig S. J. Mol. Struct. 524 (2000) 201-215
20. Ugazio E., Cavalli R., and Gasco M.R. Int. J. Pharm. 241 (2002) 341-344
21. Vankeirsbilck T., Vercauteren A., Baeyens W., Van der Weken G., Verpoort F., Vergote G., and Remon J.P. TRAC Trends Anal. Chem. 21 (2002) 869-877
22. Wartewig S., and Neubert R.H.H. Adv. Drug Deliv. Rev. 57 (2005) 1144-1170
23. Westesen K., Bunjes H., and Koch M.H.J. J. Control. Release 48 (1997) 223-236
24. Wissing S.A., and Muller R.H. Int. J. Pharm. 254 (2003) 65-68
25. Wissing S.A., and Muller R.H. Eur. J. Pharm. Biopharm. 56 (2003) 67-72